Clinical potential of bevacizumab in the treatment of metastatic and locally advanced cervical cancer: current evidence

The addition of bevacizumab to established therapies for metastatic and locally advanced cervical cancer is an area of evolving research and a potential strategy toward improving historically suboptimal outcomes for women with advanced disease. Bevacizumab, when added to first-line chemotherapy, has...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Matthew W, Rusthoven, Chad G, Fisher, Christine M, Schefter, Tracey E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037327/
https://www.ncbi.nlm.nih.gov/pubmed/24876784
http://dx.doi.org/10.2147/OTT.S49429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037327/
https://www.ncbi.nlm.nih.gov/pubmed/24876784
http://dx.doi.org/10.2147/OTT.S49429

Ejemplares similares